Cormedix Inc (NAS:CRMD)
$ 5.12 0.01 (0.2%) Market Cap: 281.39 Mil Enterprise Value: 223.47 Mil PE Ratio: 0 PB Ratio: 4.85 GF Score: 54/100

CorMedix Inc at Jefferies Healthcare Conference Transcript

Jun 08, 2023 / 03:30PM GMT
Release Date Price: $5.18 (+3.60%)
Will McNamara
(Trades, Portfolio) LLC - Analyst

Good morning, and welcome to the Jefferies Global Healthcare Conference. Will McNamara with the Jefferies investment banking team. And excited to introduce Joe Todisco, the CEO of CorMedix.

Joe Todisco
CorMedix Inc. - CEO

Thanks, Jefferies. Hi, good morning, everybody. As you said, I'm Joe Todisco. I'm the CEO of CorMedix. Thanks for being here today. This is not the clicker. Okay. So I skipped over our forward-looking statements. They're available in our SEC filings and on our website.

I thought it would be good to start with a little bit about who is CorMedix. We are a publicly traded, small-cap pre-commercial biotech company that is focused on developing therapeutic products for the prevention and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot